MEDONEFARMA

LETERMOVIR LIQUID

PRODUCT DESCRIPTION

Letermovir is an antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease.

CHEMICAL NAME

2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid.

Brand Names

Prevymis, Letermovir

Category

Antiviral (anti-infective)

DOSAGE FORM

Injection: 240mg/12mL (20mg/mL) solution for single-dose vial.

INDICATIONS

Letermovir is used alone or together with another medicine (eg, cyclosporine) to prevent cytomegalovirus (CMV) infection and disease in patients who have received an allogeneic hematopoietic stem cell (bone marrow) transplant or in patients who have received kidney transplant who have a high risk for getting CMV.

NDC CODE

00006-5003-01 and 00006-5004-01.

STORAGE & SHELF LIFE

  • Shelf life: 3 years (36 months) Unopened
  • Store at 20°C to 25°C (68°F to 77°F).

Anti-infectives

Can’t find what you are looking for?

Please call us. We would love to help.